ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,469.30
      0.39%
      US Tech 100
      19,174.00
      1.14%
      Dow Jones
      39,112.16
      -0.76%
      Brent Oil
      84.565
      0.45%
      Bitcoin
      62,000.62
      0.32%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Nyxoah SA (NYXH)

      7. Nyxoah SA (NYXH) News

      NYXH

      Nyxoah (NYXH)

      Nyxoah SA
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NYXH
      DateTimeSourceHeadlineSymbolCompany
      06/03/20244:30PMGlobeNewswire Inc.Nyxoah to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:NYXHNyxoah SA
      06/03/20244:24PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
      06/03/20244:15PMGlobeNewswire Inc.Information on the total number of voting rights and sharesNASDAQ:NYXHNyxoah SA
      06/03/20244:05PMGlobeNewswire Inc.Publication relating to transparency notificationsNASDAQ:NYXHNyxoah SA
      05/31/20244:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
      05/31/20242:00AMGlobeNewswire Inc.Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional SharesNASDAQ:NYXHNyxoah SA
      05/30/20245:20PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NYXHNyxoah SA
      05/29/20244:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
      05/28/20244:30PMGlobeNewswire Inc.Information on the Total Number of Voting Rights and SharesNASDAQ:NYXHNyxoah SA
      05/24/20244:42PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
      05/24/20244:40PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NYXHNyxoah SA
      05/23/20249:59AMGlobeNewswire Inc.Nyxoah Announces Pricing of OfferingNASDAQ:NYXHNyxoah SA
      05/22/20244:17PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NYXHNyxoah SA
      05/22/20244:14PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
      05/22/20244:10PMGlobeNewswire Inc.Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering ProgramNASDAQ:NYXHNyxoah SA
      05/22/20244:05PMGlobeNewswire Inc.Nyxoah Announces Proposed Offering of Ordinary SharesNASDAQ:NYXHNyxoah SA
      05/14/20244:11PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
      05/14/20244:05PMGlobeNewswire Inc.Nyxoah Reports First Quarter 2024 Financial and Operating ResultsNASDAQ:NYXHNyxoah SA
      05/13/20244:30PMGlobeNewswire Inc.Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024NASDAQ:NYXHNyxoah SA
      05/10/20241:00AMGlobeNewswire Inc.Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024NASDAQ:NYXHNyxoah SA
      04/11/20244:30PMGlobeNewswire Inc.Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical OfficerNASDAQ:NYXHNyxoah SA
      03/29/20244:30PMGlobeNewswire Inc.Information on the total number of voting rights and sharesNASDAQ:NYXHNyxoah SA
      03/25/20242:05AMGlobeNewswire Inc.Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery FoundationNASDAQ:NYXHNyxoah SA
      03/19/20244:05PMGlobeNewswire Inc.Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary EndpointsNASDAQ:NYXHNyxoah SA
      03/05/20244:13PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
      03/05/20244:05PMGlobeNewswire Inc.Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating ResultsNASDAQ:NYXHNyxoah SA
      02/29/20244:30PMGlobeNewswire Inc.Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceNASDAQ:NYXHNyxoah SA
      02/15/20244:30PMGlobeNewswire Inc.Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024NASDAQ:NYXHNyxoah SA
      02/14/20244:17PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NYXHNyxoah SA
      01/17/20244:12PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
       Showing the most relevant articles for your search:NASDAQ:NYXH